Clinical Trial Update: A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating safety and therapeutic effects of MNV-BM-BLD transplantation in pediatric patients with Pearson syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Diseases
• Pearson Syndrome

Drugs mentioned

• MNV-BM-BLD (MNV-BM-BLD)

Snippet

Sponsor: Minovia Therapeutics Ltd. | Conditions: Mitochondrial Diseases, Pearson Syndrome | Phase 1, Phase 2 | Status: COMPLETED